Rhumbline Advisers »

Atea Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $449k 147k 3.05
2023-09-30 $403k 134k 3.00
2023-06-30 $528k 141k 3.74
2023-03-31 $414k 124k 3.35
2022-12-31 $568k 118k 4.81
2022-09-30 $661k 116k 5.69
2022-06-30 $779k 110k 7.10
2022-03-31 $594k 82k 7.22
2021-12-31 $771k 86k 8.94
2021-09-30 $3.0M 86k 35.06
2021-06-30 $1.8M 82k 21.47
2021-03-31 $1.1M 17k 61.76
2020-12-31 $523k 13k 41.79